- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Snapshot for Eli Lilly & Co (LLY)
| Open: | 52.2800 | Day's Range: | 51.7200 - 52.3800 | Volume: | 2,067,715 |
|---|---|---|---|---|---|
| Previous Close: | 52.3500 | 52wk Range: | 41.4100 - 58.4050 | 1-Yr Rtn: | +28.37% |
Key Statistics for LLY
| Current P/E Ratio (ttm) | 14.4072 |
|---|---|
| Estimated P/E(12/2013) | 13.2383 |
| Relative P/E vs. SPX | 0.8949 |
| Earnings Per Share (USD) (ttm) | 3.6100 |
| Est. EPS (USD) (12/2013) | 3.9280 |
| Est. PEG Ratio | 9.7556 |
| Market Cap (M USD) | 58,592.46 |
| Shares Outstanding (M) | 1,126.56 |
| 30 Day Average Volume | 5,834,218 |
| Price/Book (mrq) | 3.9324 |
| Price/Sale (ttm) | 2.5621 |
| Dividend Indicated Gross Yield | 3.77% |
| Cash Dividend (USD) | 0.4900 |
| Last Dividend | 08/13/2013 |
| 5 Year Dividend Growth | 1.83% |
| Next Earnings Announcement | 07/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LLY
Company Profile & Key Executives for LLY
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company's products are sold in countries around the world. Eli Lilly's products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
| John C LechleiterChairman/President/CEO | Shaun HawkinsChief Diversity Officer |
| Maria A CrowePres:Manufacturing Operations | Derica W RiceExec VP:Global Svcs/CFO/Acting CEO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LLY News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page